Nexvet to Discuss Pivotal Study Success of Lead Program and Product Pipeline at Bank of America Merrill Lynch 2015 Animal Health Summit
December 08, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is scheduled...
Nexvet to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced that Dr. Mark Heffernan, Nexvet's Chief Executive Officer, is...
Nexvet Announces Positive Results From NV-01 Pivotal Study in Dogs With Osteoarthritis
November 16, 2015 05:30 ET
|
Nexvet Biopharma plc
Primary Endpoint Achieved
Conference Call November 16th at 9:00AM ET
DUBLIN, Ireland, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today...
Nexvet Hosting Teleconference to Provide Update on NV-01 Pivotal Study
November 14, 2015 16:55 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Nov. 14, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, will host a conference call on Monday, November 16th, 2015 at 9:00 AM Eastern Time...
Nexvet Provides Speaker Update for Animal Health Symposium in New York City
November 12, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, is pleased to provide an update on its Animal Health Symposium, which is being...
Nexvet Reports Financial Results for First Quarter of Fiscal Year 2016
November 05, 2015 06:00 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three month period ended September...
Nexvet Initiates Pilot Field Study of NV-02 for Feline Osteoarthritis Pain
October 19, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the initiation of a pilot field study for its product candidate...
Nexvet to Host Animal Health Symposium in New York City
October 06, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Oct. 6, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, is pleased to announce that it will host an Animal Health Symposium from 10:30AM to...
Nexvet Receives FY2015 Cash Refund of $3.2 Million
September 29, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced receipt of US$3.2 million in cash under the Australian Federal...
Nexvet Secures Biomanufacturing Facility and Receives IDA Ireland Support
September 16, 2015 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it has secured a dedicated biologics manufacturing facility in...